SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 157 filers reported holding SERES THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $763,404 | -50.7% | 320,758 | -0.7% | 0.00% | – |
| Q2 2023 | $1,547,203 | +8.9% | 323,007 | +29.0% | 0.00% | – |
| Q1 2023 | $1,420,159 | +1.9% | 250,469 | +0.6% | 0.00% | – |
| Q4 2022 | $1,393,862 | -12.1% | 248,904 | +0.9% | 0.00% | – |
| Q3 2022 | $1,585,000 | +117.1% | 246,805 | +15.9% | 0.00% | – |
| Q2 2022 | $730,000 | -54.5% | 212,996 | -5.6% | 0.00% | – |
| Q1 2022 | $1,605,000 | -12.7% | 225,526 | +2.2% | 0.00% | – |
| Q4 2021 | $1,838,000 | -3.7% | 220,619 | -19.5% | 0.00% | – |
| Q3 2021 | $1,908,000 | -69.3% | 274,150 | +5.2% | 0.00% | -100.0% |
| Q2 2021 | $6,215,000 | +45.5% | 260,586 | +25.6% | 0.00% | 0.0% |
| Q1 2021 | $4,271,000 | -20.2% | 207,444 | -5.0% | 0.00% | 0.0% |
| Q4 2020 | $5,349,000 | +0.5% | 218,312 | +16.1% | 0.00% | 0.0% |
| Q3 2020 | $5,322,000 | +742.1% | 187,986 | +41.5% | 0.00% | – |
| Q2 2020 | $632,000 | +54.5% | 132,827 | +15.9% | 0.00% | – |
| Q1 2020 | $409,000 | +5.7% | 114,622 | +2.1% | 0.00% | – |
| Q4 2019 | $387,000 | +6.0% | 112,246 | +23.2% | 0.00% | – |
| Q3 2019 | $365,000 | +78.0% | 91,081 | +42.4% | 0.00% | – |
| Q2 2019 | $205,000 | -66.4% | 63,951 | -28.0% | 0.00% | – |
| Q1 2019 | $611,000 | +58.3% | 88,833 | +4.1% | 0.00% | – |
| Q4 2018 | $386,000 | -35.9% | 85,364 | +7.6% | 0.00% | – |
| Q3 2018 | $602,000 | -11.9% | 79,341 | 0.0% | 0.00% | – |
| Q2 2018 | $683,000 | +0.1% | 79,341 | -14.7% | 0.00% | – |
| Q1 2018 | $682,000 | -19.0% | 92,993 | +11.9% | 0.00% | – |
| Q4 2017 | $842,000 | -37.9% | 83,090 | -1.7% | 0.00% | – |
| Q3 2017 | $1,355,000 | +48.9% | 84,496 | +4.9% | 0.00% | – |
| Q2 2017 | $910,000 | -1.4% | 80,546 | -1.6% | 0.00% | – |
| Q1 2017 | $923,000 | +13.8% | 81,850 | -0.1% | 0.00% | – |
| Q4 2016 | $811,000 | -2.2% | 81,917 | +21.4% | 0.00% | – |
| Q3 2016 | $829,000 | -50.2% | 67,464 | +17.8% | 0.00% | -100.0% |
| Q2 2016 | $1,664,000 | +59.4% | 57,270 | +45.7% | 0.00% | – |
| Q1 2016 | $1,044,000 | -15.3% | 39,299 | +11.9% | 0.00% | – |
| Q4 2015 | $1,232,000 | +106.4% | 35,110 | +74.4% | 0.00% | – |
| Q3 2015 | $597,000 | – | 20,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 14,378,802 | $342,935,000 | 4.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 122,700 | $2,926,000 | 1.30% |
| COMMODORE CAPITAL LP | 145,453 | $3,469,000 | 1.21% |
| Asymmetry Capital Management, L.P. | 63,259 | $1,509,000 | 1.04% |
| Opaleye Management Inc. | 250,000 | $5,963,000 | 0.99% |
| Ikarian Capital, LLC | 500,000 | $11,924,000 | 0.96% |
| HighVista Strategies LLC | 44,750 | $1,068,000 | 0.76% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 63,915 | $1,524,000 | 0.68% |
| Altium Capital Management LP | 104,626 | $2,495,000 | 0.58% |
| Integral Health Asset Management, LLC | 75,000 | $1,789,000 | 0.49% |